148 related articles for article (PubMed ID: 7052160)
1. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.
Burns ER; Zucker-Franklin D
Blood; 1982 Oct; 60(4):1030-7. PubMed ID: 7052160
[TBL] [Abstract][Full Text] [Related]
2. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Murphy WG
Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL
J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells.
Mitra D; Jaffe EA; Weksler B; Hajjar KA; Soderland C; Laurence J
Blood; 1997 Feb; 89(4):1224-34. PubMed ID: 9028945
[TBL] [Abstract][Full Text] [Related]
5. Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura.
Raife TJ; Atkinson B; Aster RH; McFarland JG; Gottschall JL
Am J Hematol; 1999 Oct; 62(2):82-7. PubMed ID: 10509001
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
Lian EC
Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
[TBL] [Abstract][Full Text] [Related]
7. Platelet-agglutinating protein P37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G.
Siddiqui FA; Lian EC
Blood; 1988 Feb; 71(2):299-304. PubMed ID: 3337898
[TBL] [Abstract][Full Text] [Related]
8. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura.
Wright JF; Wang H; Hornstein A; Hogarth M; Mody M; Garvey MB; Blanchette V; Rock G; Freedman J
Br J Haematol; 1999 Dec; 107(3):546-55. PubMed ID: 10583256
[TBL] [Abstract][Full Text] [Related]
9. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.
Lian EC; Harkness DR; Byrnes JJ; Wallach H; Nunez R
Blood; 1979 Feb; 53(2):333-8. PubMed ID: 570069
[TBL] [Abstract][Full Text] [Related]
10. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.
Jimenez JJ; Jy W; Mauro LM; Horstman LL; Ahn YS
Br J Haematol; 2001 Jan; 112(1):81-90. PubMed ID: 11167788
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Mori Y; Wada H; Okugawa Y; Tamaki S; Nakasaki T; Watanabe R; Gabazza EC; Nishikawa M; Minami N; Shiku H
Clin Appl Thromb Hemost; 2001 Jan; 7(1):5-9. PubMed ID: 11190905
[TBL] [Abstract][Full Text] [Related]
12. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
Murphy WG; Moore JC; Kelton JG
Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.
Valant PA; Jy W; Horstman LL; Mao WW; Ahn YS
Br J Haematol; 1998 Jan; 100(1):24-32. PubMed ID: 9450786
[TBL] [Abstract][Full Text] [Related]
15. Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
Mauro M; Kim J; Costello C; Laurence J
Am J Hematol; 2001 Jan; 66(1):12-22. PubMed ID: 11426486
[TBL] [Abstract][Full Text] [Related]
16. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
17. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
Siddiqui FA; Lian EC
J Clin Invest; 1985 Oct; 76(4):1330-7. PubMed ID: 3932464
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
19. Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells.
Praprotnik S; Blank M; Levy Y; Tavor S; Boffa MC; Weksler B; Eldor A; Shoenfeld Y
Int Immunol; 2001 Feb; 13(2):203-10. PubMed ID: 11157853
[TBL] [Abstract][Full Text] [Related]
20. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells.
Laurence J; Mitra D; Steiner M; Staiano-Coico L; Jaffe E
Blood; 1996 Apr; 87(8):3245-54. PubMed ID: 8605340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
